BlackRock, Inc. 13D and 13G filings for Inhibrx Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase | 2023-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | BlackRock Inc. BLK | 2,715,672 5.700% | 299,484 (+12.39%) | Filing |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX | BlackRock Inc. BLK | 2,416,188 5.500% | 2,416,188 (New Position) | Filing |